Should Interventional Cardiologists Be Involved in Acute Stroke?

According to this single-site study, published in J Am Coll Cardiol Intv., interventional cardiologists can safely conduct revascularizations in a setting of acute stroke, with high clinical and technical success. Cardiologists are taking on this traditional interventional neurology field simply due to the lack of interventional neurologists, who are thus unable to provide coverage 24/7, 365 days per year.

Síndrome de Hiperperfusión cerebral post-angioplastia carotídea: una complicación prevenible

However, this brings about hidden costs. Even cardiologists with great experience and technical skills have limited knowledge of intracranial anatomy, CTs, MRIs, clinical aspects, and—particularly—how to manage catastrophic complications such as intracranial bleeding.

There should be no shortcuts in training. Thinking that a given vascular disease is similar to all others is a big mistake.

Taking into account that acute stroke interventions have not improved mortality, only disability (a much softer endpoint), and that a complication such as intracranial bleeding can reach a mortality rate of up to 70%, it is easy to imagine that a slight increase in the rate of complications can translate into a prognosis that is worse than natural disease progression.


Read also: SOLACI Symposium at SOCIME Congress 2019.


The study included 70 consecutive patients who, between 2012 and 2018, underwent acute stroke intervention for large-vessel occlusion. In 61% of cases, patients received fibrinolytic therapy after baseline imaging.

The mean time between symptom onset and arrival to the cath lab was 138 minutes, and the mean door-to-vascular access time was 64 minutes.

The best aspect of this work (one that a team of interventional neurologists would have a hard time reproducing) are the mere 13 minutes required between interventional team activation and its readiness. Undoubtedly, our experience and organization in relation to acute myocardial infarction has paid up.

In most patients, thrombectomy was done with a stent retriever. An aspiration system or a combination of techniques were also used.



Read also: Best Conduits and Best Surgeons for the Best Outcome.


Recanalization was technically successful (Thrombolysis In Cerebral Infarction flow grade 2b or 3) in 93% of patients.

The 30-day mortality was 18% and favorable clinical outcome (modified Rankin scale score of 0 to 2) was achieved in 61% at 3 months.

Conclusion

Acute stroke interventions can be conducted safely and with high technical and clinical success by experienced interventional cardiologists.

Original title: Acute Stroke Interventions Performed by Cardiologists Initial Experience in a Single Center.

Reference: Marius Hornung et al. J Am Coll Cardiol Intv 2019;12:1703–10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

tromb

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....